Skip to content
HowShorted

TG THERAPEUTICS, INC. short interest in 2020

In 2020, TG THERAPEUTICS, INC.'s disclosed short interest ran from 13.93% of shares outstanding on 15 Jan 2020 to 10.38% on 31 Dec 2020, a change of -3.55 percentage points. The year's high was 13.93% on 15 Jan 2020 and its low 10.34% on 30 Nov 2020, averaging 11.87% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.09 days on 31 Aug 2020. Full history: TG THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TG THERAPEUTICS, INC. in 2020

2020 in figures

Start of year
13.93% (15 Jan 2020)
End of year
10.38% (31 Dec 2020)
Change
-3.55 pp
High
13.93% (15 Jan 2020)
Low
10.34% (30 Nov 2020)
Average
11.87%
Highest days to cover
13.09 (31 Aug 2020)
SEC filings marked
8

Every report in 2020

TG THERAPEUTICS, INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202013.93%6.20
31 Jan 202013.18%6.21
14 Feb 202012.79%10.03
28 Feb 202012.25%6.08
13 Mar 202011.99%5.4110-K filed, results (8-K)
31 Mar 202012.56%6.04
15 Apr 202012.59%10.72
30 Apr 202012.70%7.51
15 May 202011.37%3.5210-Q filed, results (8-K)
29 May 202010.70%6.69
15 Jun 202011.01%7.03
30 Jun 202012.79%8.97
15 Jul 202013.85%8.28
31 Jul 202013.21%12.30
14 Aug 202012.12%10.6010-Q filed, results (8-K)
31 Aug 202012.06%13.09
15 Sep 202011.23%7.61
30 Sep 202011.06%6.18
15 Oct 202011.04%9.49
30 Oct 202010.80%11.47
13 Nov 202010.44%11.7010-Q filed, results (8-K)
30 Nov 202010.34%13.00
15 Dec 202010.40%4.16
31 Dec 202010.38%7.80

See also: TG THERAPEUTICS, INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.